Health Law Matters

Dramatic Shift in Federal Enforcement Priorities Related to Legalized Marijuana Use

Medicinal Marijuana

In November of 2017, United States Attorney General Jeff Sessions announced that the Department of Justice (DOJ) would abide by the Rohrabacher–Blumenauer Amendment which has been interpreted as prohibiting the use of federal dollars to prosecute marijuana-industry participants in specific states that have legalized medical marijuana. Read More ›

Repeal of Obamacare’s Individual Mandate – Significant, or Not?

Stethoscope piggy bank

The individual mandate (i.e., that every American must have health insurance coverage or pay a penalty tax) has long been deemed the crux of Obamacare, or the glue that holds it all together. Read More ›

Comments Requested in New West Virginia Medical Cannabis Rules

West Virginia Medical Cannabis Regions

On December 14, 2017, the West Virginia Medical Cannabis Advisory Board announced: (1) the results of informal surveys to gauge patient need and physician interest in participation in the new medical cannabis program scheduled to be rolled out July 1, 2019; and (2) proposed rules to govern the implementation of medical cannabis programs in West Virginia. Read More ›

Kentucky Supreme Court rules for employers on maximum prices for prescription drugs under Kentucky workers’ comp and against them on employee choice of pharmacy

Prescription Drug Pricing

The Supreme Court of Kentucky held in an opinion issued August 24, 2017 that Kentucky’s regulation regarding prescription drug pricing under Kentucky’s workers’ compensation system does not require, or even suggest, that published so-called “Average Wholesale Price” (AWP) figures set by drug manufacturers should be used to determine the maximum price a pharmacy may charge. Read More ›

Kentucky Federal District Court Allows Claims in Data Breach Class Action to Proceed: Implications for Healthcare Providers.

Health Care Data Privacy

The fallout from the seemingly endless W-2 phishing scams continues to be felt. Read More ›

Last-Minute Tips for Ohio’s Medical Marijuana Processor Applicants

Medical Marijuana processed into oils and edibles

It’s already a stressful time of year, but for those vying for a license to convert marijuana plants into edibles, patches and oils, things have been thrust into overdrive. Read More ›

CMS’ Cuts to the 340B Drug Payment Program Cause Hospital Uproar

CMS Cuts to the 340B Drug Payment Program

The Centers for Medicare and Medicaid Services (CMS) recently released a Final Rule that will cut 340B drug payments to certain hospitals beginning January 1, 2018. Read More ›

Carefully Navigate Shifting Sands of Federal Enforcement Priorities Related to Medical Marijuana

State Sanctioned Medical Marijuana compliance

Under the Obama administration, the Department of Justice (DOJ) placed a low priority on pursuing charges against individuals and entities complying with state-sanctioned medical marijuana programs. However, under President Trump and his appointee, Attorney General Jeff Sessions... Read More ›

Kentucky Department for Medicaid Services Proposes Amended Managed Care Regulations

Kentucky Department for Medicaid Services Proposes Amended Managed Care regulations

On November 13, 2017, the Kentucky Department of Medicaid Services (DMS) filed amendments to nearly every regulation in 907 KAR Chapter 17, which governs Kentucky’s Medicaid Managed Care program. Read More ›

OSHA Electronic Submission Deadline Extended

OSHA electronic submission of work related injuries and illnesses

OSHA recently announced that employers now have until December 15, 2017 to electronically submit their 2016 Summary of Work-Related Injuries and Illnesses (Form 300A). Read More ›

Ask the Blogger

Do you have a topic that you would like discussed in a future blog article? Please let us know. If you have a confidential question regarding a blog article, please feel free to contact the article's author directly, or let us know if you would like for someone to contact you directly.

Attorney Spotlight

Brian F. Higgins is an associate in FBT's regulated business group with a focus on health care, and he has a history as corporate counsel to Medpace, Inc., a pharmaceutical clinical research organization.